Lung Biopsy Systems Market - Regional Analysis
North American Market Forecast
North America industry is set to hold largest revenue share of 42% by 2035, impelled by growing research and clinical trials to test a new approach to treatment for lung cancer in the region.Therefore, to support these efforts the demand for lung biopsy systems is expected to rise in the region. According to statistics, in 2021, North America saw over 25% global increase in clinical drug trial initiations.
APAC Market Statistics
The Asia Pacific lung biopsy systems market is estimated to be the second largest, during the forecast timeframe led by growing air pollution in the environment owing to the rapid urbanization and industrialization in the region. For instance, the deteriorating air pollution in India is being attributed by medical professionals to a rapid increase in cases of chest and throat sickness, and many respiratory ailments. This has led to increasing demand for lung biopsy systems in the region. India, a fast-developing nation with a growing population, suffers from severe air pollution, and it is estimated that more than 25,000 people die from it every year in Delhi.
